- Anthem : Morgan Stanley raises price target to $459 from $454, maintains overweight rating
- Arrowhead Pharmaceuticals : Piper Sandler lowers pt to $89 from $109, maintains overweight rating
- Cactus : Stifel lifts price target to $43 from $38, reiterates buy rating
- Canadian Solar : Goldman Sachs changes price target to $47 from $43, maintains neutral rating
- ChampionX : Stifel adjusts price target to $30 from $26, maintains buy rating
- Danaos : Jefferies ups price target to $90 from $87, maintains buy rating
- Diageo: Jefferies keeps its Buy rating. The target price is still set at GBp 3800.
- Franklin Covey : Roth Capital adjusts price target to $45 from $36, reiterates buy rating
- GlaxoSmithKline: JP Morgan remains Neutral. The target price is unchanged and still at GBp 1300.
- Flutter: Deutsche Bank upgrades from hold to buy with a target of GBp 16,257.
- IMI: Goldman Sachs downgrades to neutral from buy with a target of GBp 1,700.
- National Storage Affiliates Trust : Baird Analyst starts coverage at outperform with $54 price target
- NovaGold Resources : B. Riley lowers pt to $28 from $30 on higher capital expenditure assumptions, keeps buy rating
- Renalytix : Berenberg starts coverage at buy with $38 price target
- Rio Tinto: Barclays keeps Neutral rating. The target price is increased from GBp 5550 to GBp 6150.
- Santander Consumer : Janney adjusts fair value estimate to $39 from $31, maintains neutral rating
- Stagecoach: HSBC upgrades from light to hold with a target of GBp 95.
- Tesla: RBC retains his Neutral opinion on the stock. The target price continues to be set at USD 725.
- Walgreens Boots Alliance : Deutsche Bank adjusts price target to $52 from $55, maintains hold rating
- Workspace: Kempen upgrades from Sell to Neutral with a GBp 880 target.